Company: LCTX
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001193125-25-269599
Chunk: 12

Company: Lineage Cell Therapeutics, Inc.
Filing Date: 2025-11-06
Form: 10-Q
Item: Item 6
Chunk 12
---
Incorporation by Reference

     ExhibitNumber
      
     Description
      
     ExhibitNumber
      
     Filing
      
     Filing Date
      
     File No.

     3.1
      
     Restated Articles of Incorporation, as amended
      
     3.1 
      
      10-Q
      
     November 9, 2023
      
     001-12830

     3.2
      
     Certificate of Ownership
      
     3.1
      
     8-K
      
     August 12, 2019
      
     001-12830

     3.3
      
     Second Amended and Restated Bylaws
      
     3.1(a)
      
     8-K
      
     June 13, 2024
      
     001-12830

     31.1*
      
     Certification of Chief Executive Officer pursuant to Form of Rule 13a-14(a), as Adopted Pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002

     31.2*
      
     Certification of Chief Financial Officer pursuant to Form of Rule 13a-14(a), as Adopted Pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002

     32.1#
      
     Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

     101.INS*
      
     XBRL Instance Document - the instance document does not appear in the Interactive Data as its XBRL tags are embedded within the Inline XBRL document

     101.SCH*
      
     Inline XBRL Taxonomy Extension Schema With Embedded Linkbase documents 

     104*
      
     Cover page formatted as Inline XBRL and contained in Exhibit 101

* Filed herewith

# Furnished herewith